Ultragenyx to Present at Barclays Global Healthcare Conference
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) announced that CEO Emil D. Kakkis will present at the Barclays Global Healthcare Conference on March 10, 2021, at 4:45 PM ET. The presentation will be available via live and archived webcast on the company’s website for 90 days. Ultragenyx focuses on developing treatments for rare and ultra-rare genetic diseases, with a commitment to delivering effective therapies efficiently. The company emphasizes the urgency of meeting high unmet medical needs through innovative drug development strategies.
- None.
- None.
NOVATO, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that Emil D. Kakkis, M.D., Ph.D., the company's Chief Executive Officer and President, will present at the Barclays Global Healthcare Conference on Wednesday, March 10, 2021 at 4:45 PM ET.
The live and archived webcast of the presentation will be accessible from the company’s website at http://ir.ultragenyx.com/events.cfm. The replay of the webcast will be available for 90 days.
About Ultragenyx Pharmaceutical Inc.
Ultragenyx is a biopharmaceutical company committed to bringing to patients novel products for the treatment of serious rare and ultra-rare genetic diseases. The company has built a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for treatment, for which there are typically no approved therapies treating the underlying disease.
The company is led by a management team experienced in the development and commercialization of rare disease therapeutics. Ultragenyx’s strategy is predicated upon time- and cost-efficient drug development, with the goal of delivering safe and effective therapies to patients with the utmost urgency.
For more information on Ultragenyx, please visit the company's website at: www.ultragenyx.com.
Contact Ultragenyx Pharmaceutical Inc.
Investors & Media
Joshua Higa
415-660-0951
FAQ
What is the date of the Barclays Global Healthcare Conference for Ultragenyx Pharmaceutical?
Who is presenting for Ultragenyx Pharmaceutical at the Barclays conference?
How can I access the Ultragenyx Pharmaceutical presentation at the Barclays conference?
What is the focus of Ultragenyx Pharmaceutical?
What is the stock symbol for Ultragenyx Pharmaceutical?
